REBETOL: FDA Approved Drugs and User Comments
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status |
|---|---|---|---|---|
| REBETOL | RIBAVIRIN | 200MG **Indicated for use and comarketed with Interferon ALFA-2B, Recombinant (INTRON A), as Rebetron Combination Therapy** | CAPSULE;ORAL | Discontinued |
| REBETOL | RIBAVIRIN | 200MG | CAPSULE;ORAL | Prescription |
* The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
User Comments:
For Hepatitis C “48 weeks treatment of HCV 1(a b) by NHS (UK national free Medicaid? equivalent). Dosage was lowered at one point due to adverse side effects on blood count, re: haemolytic anaemia, thrombocytopenia, neutropenia. Post treatment suffered acute pancreatitis episode.Numerous other adverse side effects during and post treatment chronic (for 9 years) side effects attributable to (either/both) ribavirin and interferon – the more serious chronic effects include: depression, anxiety, memory impairment, fatigue, sleep disorder, concentration and executive function impairment. Brief episode of delusion / psychosis during treatment. Initially responded but relapsed early during treatment despite rigorous adherence to treatment schedule.”
JaiDee (taken for 6 months to 1 year) January 23, 2016
For Hepatitis C “After treatment for 48 weeks with Rebetol combined with PegInteron I no longer have virus in my system. Side effects included extreme fatigue toward the end of treatment, along with flu-like symptoms every weekend after administering the shot of PegInteron on Fridays.”
RJGatzk (taken for 6 months to 1 year) August 6, 2013